Advanced search
Publication Cover
Pharmaceutical Development and Technology Volume 3, 1998 - Issue 4
Submit an article Journal homepage
212
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Identification of Formulation and Manufacturing Variables That Influence In Vitro Dissolution and In Vivo Bioavailability of Propranolol Hydrochloride Tablets

Natalie D. Eddington Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, 100 Penn Street, AHB, Baltimore, Maryland, 21201-6808Correspondence[email protected]
,
Muhammad Ashraf Wyeth-Ayerst Research, Pearl River, New York, 10965
,
Larry L. Augsburger Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, 100 Penn Street, AHB, Baltimore, Maryland, 21201-6808
,
James L. Leslie Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, 100 Penn Street, AHB, Baltimore, Maryland, 21201-6808
,
Michael J. Fossler US. Food and Drug Administration, CDER, Rockville, Maryland, 20855
,
Lawrence J. Lesko US. Food and Drug Administration, CDER, Rockville, Maryland, 20855
,
Vinod P. Shah US. Food and Drug Administration, CDER, Rockville, Maryland, 20855
&
Gurvinder Singh Rekhi Elan Pharma, Inc., Gainesville, Georgia, 30504
 show all
Pages 535-547 | Received 27 Mar 1996, Accepted 27 Mar 1998, Published online: 27 Sep 2008

References

  • Skelly J. P. G. A., Van Burskirk Savello D. R., Amidon G. L., Arbit H. M., Dighe S., Fawzi M. B., Gonzalez M. A., Malick A. W., Malinowski H., Nedich R., Peck G. E., Peace D. M., Shah V., Shangraw R. F., Schwartz J. B., Truelove J. Workshop Report, Scale-up of immediate release oral solid dosage forms. Pharm. Res. 1993; 10(2)313–316
  • Amidon G. L., Lennernas H., Shah V. P., Crison J. R. A theoretical basis for a biopharmaceutical drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 1995; 12(3)413–420
  • Scale-up and post approval changes (SUPAC-IR) guidance. Fed. Regist. 1995; 60(230)61638–61643
  • Augsburger L. L., Shangraw R. F., Lesko L. J., Williams R. L. An approach toward establishing a scientific foundation for interpreting regulations and workshop on scale-up and post approval changes. Pharm. Res. 1994; 11(10)S–143
  • Windholz M. The Merck Index11 th ed. Merck and Co., Inc., Rahway, NJ 1989
  • Walle T., Conradi E. C., Walle U. K., Fagan T. C., Gaffney T. E. 4-hydroxypropranolol and its glucuronide after single and long-term doses of propranolol. Clin. Pharmacol. Ther. 1980; 27(1)22–31
  • Rekhi G. S., Ashraf M., Augsburger L. L., Schwartz P., Lesko L. J. Identification of critical formulation and processing variables for propranolol hydrochloride tablets. Pharm. Res. 1994; 11(9)S–163
  • Physician's Desk Reference48th ed. Medical Economics Data Production Co., Montvale, NJ 1994
  • United States Pharmacopeia22nd ed. The United States Pharmacopeial Convention, Rockville, MD 1990
  • Guidance on statistical procedures for bioequivalence studies using a standard two-treatment crossover design. FDA, Office of Generic Drugs (OGD). Division of Bio-equivalence, Rockville, MD 1992
  • Peck G. E., Baley G. J., McCurdy V. E., Banker G. S. Tablet formulation and design. Pharmaceutical Dosage Forms: Tablets, H. A. Leiberman, L. Lach-Man, J. B. Schwartz. Marcel Dekker, Inc., New York 1989; Vol 1: 109
  • Mehta A. M., Augsburger L. L. A preliminary study of the effect of slug hardness on drug dissolution from hard gelatin capsules filled on an automatic capsule-filling machine. Int. J. Pharm. 1981; 7(4)327–334
  • Shangraw R. F. Compressed tablets by direct compression. Pharmaceutical Dosage Forms: Tablets, H. A. Leiberman, L. Lachman, J. B. Schwartz. Marcel Dekker, Inc., New York 1989; Vol 1: 214–217
  • Singh Rekhi G., Eddington N. D., Fossler M. J., Schwartz P., Lesko L. J., Augsburger L. L. Evaluation of in vitro release rate and in vivo absorption characteristics of four metoprolot tartrate immediate release tablet formulations. Pharm. Dev. Technol. 1997; 2(1)11–24
  • Eddington N. D., Rekhi G. S., Demarest D. A., Jr, Leslie J. L., Kharidia J., Shah V. P., Lesko L. J., Augsburger L. L. The influence of scale-up on the in-vivo bioavailability of propranolol hydrochloride tablets. Pharm. Res. 1996; 12(9)S–416

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.